Clinical feature and sural biopsy study in nitrous oxide-induced peripheral neuropathy

PLoS One. 2022 Sep 16;17(9):e0274765. doi: 10.1371/journal.pone.0274765. eCollection 2022.

Abstract

Objective: The objective was to analyze the clinical characteristics and pathological characteristics of sural biopsy in nitrous oxide (N2O) -induced peripheral neuropathy.

Methods: We recruited 18 patients with N2O abuse-induced neurological disorders and reported their demographic data, clinical manifestations, laboratory examinations, and nerve conduction studies. Seven patients underwent sural nerve biopsy pathologic examination.

Results: All 18 patients had polyneuropathy, the nerve conduction results showed significant reductions in motor and sensory amplitudes, slowing of conduction velocities, and prolongation of latencies in most tested nerves compared to the controls. Toluidine blue staining of semi-thin sections of sural nerve biopsy showed decreased myelinated nerve fiber density, increased thin myelinated nerve fiber density, and axonal regeneration. Electron microscopy showed axonal degeneration and nerve regeneration.

Conclusion: The main manifestations of peripheral nerve damage caused by the abuse of N2O are lower limb weakness and distal sensory disorder. The nerve conduction study results demonstrated that mixed axonal and demyelinating neuropathy was the most common type of neuropathy. Sural biopsy showed the main pathological change was chronic axonal degeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biopsy
  • Humans
  • Nitrous Oxide / adverse effects
  • Peripheral Nerve Injuries* / pathology
  • Polyneuropathies* / chemically induced
  • Polyneuropathies* / pathology
  • Sural Nerve / pathology
  • Tolonium Chloride

Substances

  • Tolonium Chloride
  • Nitrous Oxide

Grants and funding

This study was supported by research grants from the First Hospital of Tsinghua University Pilot Funds (LH-02, study design, data collection and analysis) and China-Japan Friendship Hospital Young talents funds (2015-QNYC-A-05, data collection).